Nectin Therapeutics vs OncoDecipher
Nectin Therapeutics vs OncoDecipher, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Nectin Therapeutics is on 50/100 and OncoDecipher on 43/100.
Where each one leads
Nectin Therapeutics
- our overall score: 50/100 against 43/100
- funding raised: $64.1M against $1.0M
OncoDecipher
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Nectin Therapeutics | OncoDecipher |
|---|---|---|
| What it is | Biotech company developing next-generation immunotherapy agents to unlock the immune system. | OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability. |
| Category | Life Sciences, Immunotherapy, Immunology, Cancer | Life Sciences, Cancer, Oncology, Mutation |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software |
| Founded | 2016 | 2015 |
| Headquarters | Not published | Cambridge, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Nectin Therapeutics | OncoDecipher |
|---|---|---|
| Employees | 11 | Not published |
| Headcount growthLast 12 months | +2.9% | Not published |
| Total funding | $64.1M | $1.0M |
| Latest round | Series C | Seed |
| LinkedIn followers | 1,591 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Nectin Therapeutics | OncoDecipher |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 50/100 | 43/100 |
| Traction | 50/100 | 30/100 |
| Team | 30/100 | 60/100 |
| Search visibility | 30/100 | 3/100 |
| Quality | 58/100 | 52/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | Not published |
| Domain ratingLink authority, 0-100 | 23/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Nectin Therapeutics | OncoDecipher |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4, Segment | Not detected |
Nectin Therapeutics vs OncoDecipher: common questions
Which is better, Nectin Therapeutics or OncoDecipher?
On our 0-100 score Nectin Therapeutics rates higher (50/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Nectin Therapeutics and OncoDecipher compare on the numbers?
Nectin Therapeutics leads on our overall score (50/100 against 43/100), funding raised ($64.1M against $1.0M).
Read the full Nectin Therapeutics review and pricing or the OncoDecipher review and pricing. You can also browse other Nectin Therapeutics alternatives we track.